Screening for prostate cancer
Published in NPS Direct
Date published: About this date
Prostate cancer is the most common malignancy in Australian men. Does measuring the concentration of prostate specific antigen (PSA) in the blood help in the assessment and management of early prostate cancer? RACGP guidelines recommend against routine PSA screening unless the man specifically asks for it and is fully counselled on the pros and cons. Without understanding the underlying biology or without applying refinements measuring prostate specific antigen may result in more harm than good.